Health Product Shortages homepage

Welcome to Health Product Shortages Canada, the website for mandatory reporting of health product shortages and discontinuations by regulated parties. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the health products they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca (open in new tab).

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

List of shortage reports
Brand name Company Name Status Strength Update Date Updated View Report
TEMODAL MERCK CANADA INC Anticipated shortage 5MG New Report 2026-04-17 283145
XOFLUZA HOFFMANN-LA ROCHE LIMITED Anticipated shortage 20MG Updated Report 2026-04-17 283141
DAUNORUBICIN HYDROCHLORIDE INJECTION HIKMA CANADA LIMITED Resolved 20MG Updated Report 2026-04-17 271038
APO-ATOMOXETINE APOTEX INC Resolved 25MG Updated Report 2026-04-17 276970
ANAFRANIL APOTEX INC Actual shortage 25MG Updated Report 2026-04-17 281626
ALYSENA 21 APOTEX INC Resolved 20MCG 100MCG Updated Report 2026-04-17 281623
APO-FLUCONAZOLE APOTEX INC Actual shortage 50MG Updated Report 2026-04-17 281617
TECTA TAKEDA CANADA INC Actual shortage 40MG New Report 2026-04-16 283128
TRURAPI SANOFI-AVENTIS CANADA INC Anticipated shortage 100UNIT Updated Report 2026-04-16 283125
TOUJEO SOLOSTAR SANOFI-AVENTIS CANADA INC Anticipated shortage 300UNIT Updated Report 2026-04-16 283122

Discontinuation Reports

List of discontinuation reports
Brand name Company Name Status Strength Update Date Updated View Report
TRYPTAN BAUSCH HEALTH, CANADA INC. To be discontinued 750MG New Report 2026-04-16 283097
TRYPTAN BAUSCH HEALTH, CANADA INC. To be discontinued 1G New Report 2026-04-16 283051
CANCIDAS MERCK CANADA INC Discontinued 50MG Updated Report 2026-04-15 273084
SYNPHASIC 21 TABLETS PFIZER CANADA ULC Discontinued 1.0MG 0.035MG 0.035MG 0.5MG Updated Report 2026-04-15 270053
SANDOZ RISPERIDONE SANDOZ CANADA INCORPORATED Discontinued 4MG New Report 2026-04-15 282918
Get it on Google Play Download on the App Store